UMass Investigators Near ALS Breakthrough

As reported by Scott O'Connell in Telegram: Researchers at UMass Medical School on Wednesday announced a potential new breakthrough in the treatment of amyotrophic lateral sclerosis. The proposed gene therapy technique, which involves using synthetic microRNAs to...

Phase III ALS Trial “REFALS” Recruiting Patients

Amyotrophic lateral levosimendan (ALS) is a rare and deadly disease with no known cure. The disease causes the death of motor neurons, ultimately evolving into paralysis. Death often occurs within 3-5 years of diagnosis—typically from respiratory failure. The...

Pin It on Pinterest